Clinical Data Management (CDM) Vendor Selection Guide

The buyer problem

An EDC or eClinical platform is a multi-year commitment made early in a trial, and switching mid-study is expensive and disruptive. Vendor marketing rarely surfaces the details that matter most when something goes wrong: real uptime history, support response time during database lock, and exactly what happens to your data if you need to migrate platforms.

What a clinical data management (cdm) vendor selection guide vendor does

A clinical data management vendor supplies the software sponsors and CROs use to build a trial database, capture and clean data from sites, manage queries, support randomization and trial supply (IRT/RTSM), collect patient- or clinician-reported outcomes (eCOA/ePRO), and process electronic informed consent (eConsent). Modern vendors increasingly bundle several of these into one eClinical platform rather than selling EDC as a standalone product.

Methods and techniques

• Electronic data capture (EDC) study build
• Randomization and trial supply management (IRT/RTSM)
• Electronic clinical outcome assessment (eCOA/ePRO)
• eConsent and remote patient engagement tools
• Data cleaning, query management, and database lock
• System validation and 21 CFR Part 11 documentation

What to verify before you retain

• 21 CFR Part 11 / GxP compliance documentation. Request the vendor's validation package and audit trail documentation showing the platform meets 21 CFR Part 11 electronic-records requirements.
• Uptime and support SLAs. Ask for real, historical uptime figures (not marketing claims) and the support response-time SLA for a production study, including nights and weekends during critical periods like database lock.
• Data export and migration terms. Confirm what format your data exports in at trial close, whether you retain full access after the contract ends, and what a mid-study platform migration would cost and take.
• Study build timeline and change-control process. Ask how long a standard study build takes and how mid-study protocol amendments are handled in the live database.
• Integration support. If you need integration with a central lab, ePRO vendor, or CTMS, confirm the platform has a proven integration, not just an API that's never been used in production.

Questions to put in your RFP

1. Can you provide your platform's 21 CFR Part 11 validation package and recent audit trail documentation?
2. What is your platform's actual historical uptime, and what is your support SLA during critical periods like database lock?
3. What format does our data export in, and what does a mid-study migration to another platform cost and take?
4. What is your typical study-build timeline, and how do you handle a live protocol amendment?
5. Do you have a proven, production integration with our central lab, ePRO vendor, or CTMS, or would this be a first-time build?
6. What is included in standard pricing versus billed as a change order (extra forms, extra sites, extra users)?

Red flags

• Cannot produce a 21 CFR Part 11 validation package on request.
• Vague or unverifiable uptime claims with no historical data offered.
• Unclear or restrictive terms on data export and ownership after contract end.
• No proven track record integrating with the specific systems you need to connect.
• Pricing structure that leaves most real usage to uncapped change orders.

Standards and governing bodies

Bodies referenced in this category. Listed for context; they do not endorse this index or any vendor. Verify any credential directly with the issuing body.

FDA / 21 CFR Part 11

U.S. Food and Drug Administration electronic records rule. The FDA regulation governing electronic records and electronic signatures used in regulated clinical trial data systems.

ICH E6(R2)

International Council for Harmonisation E6(R2). The Good Clinical Practice addendum that sets expectations for computerized systems and data integrity in modern, often decentralized, clinical trials.